On Feb. 23, 2021, Cue Health announced that its molecular point-of-care COVID-19 Test had received the CE mark, clearing it for sale and distribution in the European Union (EU).

The Cue COVID-19 Test is a highly sensitive and specific nucleic acid amplification test (NAAT) that runs on the Cue Health Monitoring System, displaying test results directly on a connected mobile smart device in about 20 minutes via the Cue Health App.